(Q67829953)
Statements
Seraspenide (acetylSDKP): phase I-II trial study of inhibitor of hematopoiesis protects against toxicity of aracytine and ifosfamide monochemotherapies (English)
Mathieu-Tubiana N
P. Carde
C. Chastang
E. Goncalves
N. Mathieu-Tubiana
E. Vuillemin
V. Delwail
O. Corbion
A. Vekhoff
F. Isnard
1 January 1992